Author:
Huang Xi-Ping,Thiessen Jake J.,Spino Michael,Templeton Douglas M.
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Agarwal MB, Viswanathan C, Ramanathan J, Massil DE, Shah S, Gupte SS, et al. Oral iron chelation with L1. Lancet. 1990;335:601.
2. Hoffbrand AV. Deferiprone therapy for transfusional iron overload. Best Pract Res Clin Haematol. 2005;18:299–317.
3. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 2006;107:3733–7.
4. Pennel DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, et al. Randomized controlled trial of deferiprone or deferoxamine in β-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 2006;107:3738–44.
5. Singh S, Epemolu RO, Dobbin PS, Tilbrook GS, Ellis BL, Damani LA, et al. Urinary metabolic profiles in human and rat of 1, 2-dimethyl- and 1, 2-diethyl substituted 3-hydroxypyridin-4-ones. Drug Metab Disposit. 1992;20:256–61.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献